Dynamic phosphorylation of Fascin-1 orchestrates microglial phagocytosis and neurological recovery after spinal cord injury

Abstract The persistence of myelin debris after spinal cord injury (SCI) constitutes a formidable barrier to axonal regeneration, remyelination, and functional recovery by initiating inflammatory cascades. Microglia, known for their superior phagocytic and degradative capabilities, are crucial in cl...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanchang Liu, Fei Yao, Ziyu Li, Yan Jiang, Jianjian Li, Shuisheng Yu, Xuyang Hu, Fangru Ouyang, Meige Zheng, Li Cheng, Juehua Jing
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Journal of Neuroinflammation
Online Access:https://doi.org/10.1186/s12974-025-03445-z
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract The persistence of myelin debris after spinal cord injury (SCI) constitutes a formidable barrier to axonal regeneration, remyelination, and functional recovery by initiating inflammatory cascades. Microglia, known for their superior phagocytic and degradative capabilities, are crucial in clearing myelin debris. Yet, the molecular mechanisms governing their function remain elusive. Our previous research has identified a sustained upregulation of Fascin-1, an actin-binding protein essential for phagocytosis, in Cx3cr1+ microglia after SCI. Here, we reveal that ablation of microglial Fascin-1 exacerbates neuronal loss and hampers motor recovery after SCI, correlating with diminished microglial phagocytic activity in Cx3cr1 cre+/− ;Fascin-1 fl/fl mice. We demonstrated that dysregulated Fascin-1 phosphorylation impairs microglial phagocytosis, linked to the upstream Mas1/Protein kinase C gamma (PKCγ) axis. Pharmacologic activation of the Mas1/PKC axis to drive Fascin-1 phosphorylation in microglia restores phagocytic function, thereby alleviating neuronal loss and facilitating neurological recovery after SCI. Our findings underscore the critical role of Fascin-1 phosphorylation in microglial phagocytosis and highlight the Mas1/PKCγ axis as a promising therapeutic target for SCI.
ISSN:1742-2094